Haleon plc (NYSE:HLN) Short Interest Update

Haleon plc (NYSE:HLN) was the recipient of a large increase in short interest in November. As of November 30th, there was short interest totalling 12,420,000 shares, an increase of 5.8% from the November 15th total of 11,740,000 shares. Based on an average daily volume of 6,260,000 shares, the days-to-cover ratio is currently 2.0 days. Currently, 0.3% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HLN. Morgan Stanley lifted their price target on shares of Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research report on Friday, September 20th. UBS Group raised shares of Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Haleon has an average rating of “Buy” and an average target price of $10.95.

Haleon Stock Up 0.3 %

NYSE HLN opened at $9.76 on Monday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The business has a 50 day moving average price of $9.75 and a two-hundred day moving average price of $9.53. The stock has a market cap of $44.18 billion, a PE ratio of 28.71, a P/E/G ratio of 2.95 and a beta of 0.28.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Blue Trust Inc. boosted its holdings in Haleon by 30.0% in the second quarter. Blue Trust Inc. now owns 24,734 shares of the company’s stock valued at $210,000 after purchasing an additional 5,712 shares during the last quarter. Raymond James & Associates boosted its stake in shares of Haleon by 14.7% during the 2nd quarter. Raymond James & Associates now owns 4,019,978 shares of the company’s stock valued at $33,205,000 after buying an additional 515,651 shares during the last quarter. First Horizon Advisors Inc. grew its position in shares of Haleon by 11.6% during the second quarter. First Horizon Advisors Inc. now owns 15,104 shares of the company’s stock worth $125,000 after buying an additional 1,568 shares in the last quarter. Fifth Third Bancorp increased its stake in shares of Haleon by 8.2% in the second quarter. Fifth Third Bancorp now owns 374,010 shares of the company’s stock worth $3,089,000 after buying an additional 28,394 shares during the last quarter. Finally, Aaron Wealth Advisors LLC raised its holdings in Haleon by 16.3% in the second quarter. Aaron Wealth Advisors LLC now owns 23,735 shares of the company’s stock valued at $196,000 after acquiring an additional 3,330 shares in the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.